Issue 64 February 2014
2. Clinical Utility of CGM in pre-diabetes and its impact on modifying lifestyles
This original research was presented by Research team at Jothydev’s Diabetes Research Centre headed by Dr.Jothydev Kesavadev at the 7th International Conference of Advanced Technologies & Treatments (ATTD) at Vienna, Austria.

Glycemic excursions in pre-diabetes are seldom evaluated in clinical practice. We assessed clinical utility of CGM in pre-diabetes and its impact on modifying lifestyles to prevent diabetes.

6 patients were enrolled in 3 month study via convenience sampling based on ability and willingness to follow instructions. Mean age 48.5 yrs, mean BMI 26.73 kg/m2. Measured blood glucose were <126 mg/dl during fasting and <150 mg/dl post breakfast. CGM was performed using iPro2 recorder at 0 and 3 months(5-7 days).Advice on lifestyle modifications were repeated once in 2 weeks by a multi-disciplinary team of doctors, dietitians, pharmacist, nurse educators, device technician, psychologist etc. who made detailed analyses of CGM recordings.

Trends observed in CGM at month 0 included hyperglycemic spikes 30- 90 mins after breakfast and dinner and glycemic variability missed in usual SMBG. At 3 months, CGM revealed smooth curves with average weight reduction of 2.35 kgs.(Table) CGM may prove an excellent tool to unravel glycemic excursions most often missed in SMBG in pre-diabetes patients. CGM could evolve as motivational tool in pre-diabetes patients to prevent progression to overt diabetes.



CGM Parameters
(n =6)

Mean
(mg/dl)
(0 month)

Standard
deviation
(0 month)

Mean
(mg/dl)
(3 months)
Standard
deviation
(3 months)

FBS 110.8 20.77 91 6.42
HbA1c 5.9% 0.38 5.4% 0.28

No: of High Excursion 7.2 5.23 2.2 2.14
No: of Low Excursion 2.8 3.82 1.5 1.52
Highest Sensor Value 178.2 28.99 151.5 6.44
Lowest Sensor Value 66 12.33 73.8 3.06
Duration within 70-40 mg/dl 89.7 9.27 96.3 2.73




Read more
Previous | Home | Next